NJ-J.M.-HUBER
Huber Engineered Materials (HEM), a leading global producer of specialty performance ingredients for industrial and consumer products and a division of the J.M. Huber Corporation (Huber), announces that Dan Krawczyk has been appointed HEM President, effective Nov. 1, 2017. Krawczyk remains a member of the HEM Board of Directors and Huber Management Council.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171114006056/en/
Before becoming the President of HEM, Krawczyk served as Huber’s Executive Vice President (EVP) of Strategy & Corporate Development since 2013. He brings more than 20 years of experience in industrial and consumer products, including expertise in financial management, strategy, corporate development, marketing and operations to his new leadership role. A native of the Detroit area, Krawczyk earned an MBA as well as an MS and BS in Electrical Engineering from the University of Michigan.
Prior to joining Huber, Krawczyk was EVP and Chief Financial Officer of Gibson Guitar Corporation. He also was Global Vice President of Business Development and Strategic Marketing for Belden and has held financial and operational leadership roles at DTE Energy, Delphi Automotive and Ford Motor Company.
Looking ahead, Krawczyk plans to lead HEM into a new era of growth and change in order to successfully position the company for future generations of shareholders and employees.
“Building on a strong track record of focused market leadership, superior customer service and operational excellence, HEM has a unique opportunity today to leverage its manufacturing and applications expertise in order to pursue growth in its core businesses and expand across a range of premium functional ingredient business segments,” Krawczyk said. “We look forward to creating long-term sustainable value for all the HEM stakeholders.”
Krawczyk’s leadership was instrumental in Huber’s largest acquisition in over 10 years, the 2016 purchase of the Martinswerk business from Albemarle Corporation to become part of HEM’s already successful Fire Retardant Additives (FRA) business unit and create a global leading non-halogen flame retardants business. This move marked the latest in a series of investments in FRA, including the acquisition of the Kemgard® smoke suppressant product line from Sherwin-Williams in 2010 and purchase of the Almatis specialty hydrates business in 2012. In addition, Krawczyk led Huber’s $630 million sale of HEM’s Silica business unit to Evonik Industries AG in 2017.
About Huber Engineered Materials (www.hubermaterials.com )
Huber Engineered Materials, headquartered in Atlanta, Georgia (US), is a global business focused on engineered specialty ingredients that enhance the performance, appeal and processing of a broad range of products used in industrial and consumer-based applications. With an expertise in inorganic materials, it has a portfolio of high value products: alumina trihydrate, magnesium hydroxide, molybdate compounds, specialty aluminas and oxides, organic matting agents, barium sulfate and industrial, food and USP grade calcium carbonate.
About J.M. Huber Corporation (www.huber.com )
J.M. Huber Corporation, headquartered in Edison, New Jersey (US), operates a portfolio of companies with a focus on its core engineered materials businesses. Founded in 1883, Huber is one of the largest family-owned companies in the US. The diversified, multinational company creates products that are used in a broad range of consumer and industrial applications, including personal care, food, beverage, pharmaceuticals and building materials.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171114006056/en/
Contact:
Huber Engineered Materials
Keith Sorrell, 678-247-2730
keith.sorrell@huber.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 09:15:00 CEST | Press release
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 09:00:00 CEST | Press release
Show Reconvenes at Paris Expo Porte de Versailles with Global Representation of Industry Leaders and Telco Experts Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 09:00:00 CEST | Press release
New Collection Features an Evolution in Design that Cuts Through the Wind for That Aerodynamic Feel on Every Run Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vic
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom